Gangde H. Zhao - Publications

Metabolic factor-based machine learning model for mortality prediction in acute hepatitis E: Development and validation from a dual-center cohort.

Journal: Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver

Published: December 04, 2025

Deep learning-based automated assessment of hepatic fibrosis via magnetic resonance images and nonimage data.

Journal: Quantitative imaging in medicine and surgery

Published: November 10, 2024

Clinicopathological analysis of gastric adenocarcinoma with elevated serum alpha-fetoprotein and enteroblastic differentiation

Journal: Zhonghua zhong liu za zhi [Chinese journal of oncology]

Published: July 22, 2024

Difficulty in differentiating liver injury from an immune checkpoint inhibitor from chemotherapy.

Journal: Frontiers in pharmacology

Published: June 23, 2024

Liver fibrosis is closely linked with metabolic-associated diseases in patients with autoimmune hepatitis.

Journal: Hepatology international

Published: June 11, 2024

The safety concerns regarding immune checkpoint inhibitors in liver cancer patients rising mainly from CHB.

Journal: Frontiers in pharmacology

Published: February 12, 2023

The 20 years transition of clinical characteristics and metabolic risk factors in primary liver cancer patients from China.

Journal: Frontiers in oncology

Published: November 28, 2022

Genetic Variations of ALDH (rs671) Are Associated With the Persistence of HBV Infection Among the Chinese Han Population.

Journal: Frontiers in medicine

Published: November 09, 2021

A novel model based on qAnti-HBc and conventional biomarkers for identifying significant liver injury among CHB patients with ALT ≤ ULN.

Journal: Antiviral research

Published: September 14, 2021

Application of Fatty Liver Inhibition of Progression Algorithm and Steatosis, Activity, and Fibrosis Score to Assess the Impact of Non-Alcoholic Fatty Liver on Untreated Chronic Hepatitis B Patients.

Journal: Frontiers in cellular and infection microbiology

Published: June 30, 2021

External Validation of aMAP Hepatocellular Carcinoma Risk Score in Patients With Chronic Hepatitis B-Related Cirrhosis Receiving ETV or TDF Therapy.

Journal: Frontiers in medicine

Published: March 15, 2021

The Use of NACSELD and EASL-CLIF Classification Systems of ACLF in the Prediction of Prognosis in Hospitalized Patients With Cirrhosis.

Journal: The American journal of gastroenterology

Published: August 29, 2020